Anaplastic thyroid cancer – Life with Disease

Go back

Anaplastic thyroid cancer is one of the rarest and most aggressive forms of thyroid cancer, accounting for less than 2% of all thyroid cancer cases but responsible for a significant portion of thyroid cancer-related deaths. Despite its rarity, this type of cancer grows with alarming speed, often spreading to other parts of the body within weeks or months of its first appearance. Understanding what to expect and how families can support patients through this challenging diagnosis is essential for navigating the difficult journey ahead.

Prognosis and Survival Outlook

When someone receives a diagnosis of anaplastic thyroid cancer, the prognosis is unfortunately very serious. This form of cancer carries one of the poorest survival rates among all cancers affecting humans. The average survival time after diagnosis ranges from three to six months, though this can vary significantly based on the stage of the disease and the patient’s overall health condition.[1][2]

The statistics are sobering but important to understand. The overall five-year survival rate for anaplastic thyroid cancer is less than 5%, with most patients passing away within just a few months of diagnosis.[4] Some studies indicate that 10% to 15% of patients survive longer than one year, while three-year and five-year survival remains very rare.[6] The median survival for the entire group of patients is approximately six months from diagnosis.[2]

The stage at diagnosis plays a crucial role in determining survival expectations. According to recent staging systems, patients whose cancer remains confined to the thyroid (Stage IVA, which occurs about 10% of the time) have a median survival of approximately 15.8 months. When the cancer has spread to the neck, including lymph nodes (Stage IVB, occurring about 40% of the time), median survival drops to about 6.1 months. When distant spread to organs like lungs, bones, or brain has already occurred at diagnosis (Stage IVC, happening about 50% of the time), the median survival is only 2.8 months.[1][15]

⚠️ Important
While survival statistics are valid for groups of patients, they cannot predict what will happen to any individual person. Every patient is unique, and there are documented cases of long-term survivors of anaplastic thyroid cancer who have lived for years after aggressive treatment. These statistics should not become a self-fulfilling prophecy, as determined pursuit of treatment despite the odds may help improve outcomes.

However, it is important to maintain realistic hope. While the outlook is often poor, some people with anaplastic thyroid cancer have lived for years after treatment, particularly those whose disease was caught early and could be completely removed surgically.[1][4] Recent advances in treatment, including targeted therapies that work against specific genetic mutations found in some tumors, are offering new possibilities for extending and improving life for certain patients.[12]

Natural Progression Without Treatment

Understanding how anaplastic thyroid cancer develops if left untreated helps patients and families grasp the urgency of beginning treatment as quickly as possible. This cancer is characterized by extraordinarily rapid growth, making it one of the fastest-growing tumors known in humans.[2][13]

The disease typically begins as a lump or mass in the neck that appears suddenly, often growing noticeably larger over a period of just days or weeks.[5] This is markedly different from other types of thyroid cancer, which tend to grow slowly over months or years. Many patients or their family members notice the lump because it becomes visible or can be felt easily. The mass is typically hard, like a rock, and may be painful to the touch.[4]

As the tumor continues to grow without intervention, it begins to press on nearby structures in the neck. The windpipe (trachea) may become compressed, leading to increasing difficulty breathing, especially when lying flat. The food pipe (esophagus) can also be affected, causing progressive difficulty swallowing food and even liquids. Some patients find that pills get “stuck” when they try to swallow them.[4][5]

The tumor may invade into the vocal cord nerves, causing hoarseness or complete voice changes. Some patients develop a harsh, difficult breathing sound called stridor, which occurs when the airway becomes severely restricted.[5] In the most severe cases, the tumor can grow so large and compress the airway so completely that it becomes a medical emergency requiring immediate intervention to prevent death by suffocation.[5]

Anaplastic thyroid cancer spreads aggressively not only locally but also to distant parts of the body. Without treatment, the cancer commonly spreads to the lungs and bones. Brain metastases can also occur. In fact, in about half of all patients with anaplastic thyroid cancer, the disease has already spread to distant organs by the time it is first diagnosed.[5][8]

The cancer also frequently spreads to lymph nodes in the neck early in its course. It can invade into major blood vessels, muscles, and other structures surrounding the thyroid gland. This local invasiveness is one reason why complete surgical removal is often impossible, even when the tumor is discovered relatively early.[3]

Possible Complications

Patients with anaplastic thyroid cancer face numerous potential complications, both from the disease itself and sometimes from the aggressive treatments required to manage it. Understanding these complications helps patients and families prepare for challenges that may arise.

One of the most serious and immediate complications is airway obstruction. As the tumor grows in the neck, it can compress or invade the trachea, making breathing progressively more difficult. This can happen quite rapidly, sometimes over just days or weeks. In emergency situations, a procedure called a tracheostomy may be necessary. This involves creating an opening in the neck below the tumor and placing a plastic tube directly into the windpipe to allow air to bypass the obstruction. While this procedure can be life-saving, it changes how the person breathes and speaks, which can be emotionally difficult to adjust to.[5]

Difficulty swallowing represents another major complication. As the tumor presses on or invades the esophagus, patients may find it increasingly hard to eat and drink normally. Pills may become impossible to swallow. Weight loss often follows, as getting adequate nutrition becomes challenging. In some cases, a feeding tube must be inserted through the abdominal wall directly into the stomach or intestine to ensure the person receives proper nutrition.[5]

Pain is a significant concern for many patients. The tumor itself can cause pain in the neck region. If the cancer spreads to bones, it can cause severe bone pain that may require strong pain medications to control. Nerve involvement can lead to pain that radiates to different areas or causes unusual sensations like numbness or tingling.[1]

When anaplastic thyroid cancer spreads to the lungs, it can cause coughing, shortness of breath, or even coughing up blood. Lung metastases may make breathing progressively more difficult and reduce the person’s ability to be physically active. Brain metastases can cause neurological problems such as headaches, seizures, weakness, balance problems, or changes in thinking and personality.[1]

Swollen lymph nodes in the neck are common as the cancer spreads locally. These can create additional visible lumps and may contribute to discomfort or difficulty with neck movement. The cancer’s invasion into neck structures can also affect the nerves controlling the vocal cords, leading to vocal cord paralysis. This causes permanent hoarseness or voice loss and can also increase the risk of choking when eating or drinking.[1]

Treatment complications can also arise. Surgery, when possible, carries risks including bleeding, infection, and damage to surrounding structures. Radiation therapy to the neck can cause skin irritation, difficulty swallowing, dry mouth, and changes in taste. Chemotherapy may lead to nausea, fatigue, lowered blood counts that increase infection risk, and other side effects depending on the specific drugs used. The combination of treatments can be physically exhausting and emotionally draining.[11]

Impact on Daily Life

A diagnosis of anaplastic thyroid cancer affects virtually every aspect of a person’s daily life, creating physical, emotional, social, and practical challenges that extend to the entire family.

Physically, patients often experience dramatic changes in their abilities. The difficulty breathing and swallowing can make even basic activities like eating a meal or climbing stairs exhausting. Many patients lose significant amounts of weight, becoming weak and frail. If a tracheostomy is needed, the person must learn a completely new way of breathing and speaking, which takes time and patience. Voice changes or loss can make communication frustrating, especially on the telephone or in noisy environments.[4]

Work becomes difficult or impossible for most patients. The rapid progression of the disease, combined with the intensity of treatment schedules, usually means taking extended time away from employment. This can create significant financial stress, particularly when it comes to medical bills and lost income. Patients who previously defined themselves by their careers may struggle with a sudden loss of professional identity and purpose.

Social relationships often change dramatically. Some patients feel self-conscious about visible changes in their neck, the presence of a tracheostomy, or their altered voice. This may lead to withdrawal from social activities and isolation at a time when connection with others is most needed. Friends and extended family may not know what to say or how to help, leading to awkward interactions or well-meaning but hurtful comments.

Hobbies and recreational activities that once brought joy may become impossible or need significant adaptation. Physical activities like sports, hiking, or dancing may be too demanding. Even quieter pursuits like singing in a choir or reading aloud to grandchildren may no longer be possible if voice problems develop. Finding new ways to experience pleasure and meaning becomes an important challenge.

The emotional toll is enormous for both patients and families. Fear about death and dying is natural and common. Anxiety about the rapid progression of the disease and uncertainty about what will happen next can be overwhelming. Depression is understandable given the circumstances, as patients grieve the loss of their previous health, independence, and future plans. Anger and frustration about the unfairness of this rare and aggressive cancer are normal reactions.

For caregivers, the burden can be intense. Spouses, adult children, or other family members often must quickly take on extensive caregiving responsibilities. This might include helping with bathing and dressing, managing medications, attending multiple medical appointments, handling feeding tubes or tracheostomy care, and providing emotional support. The caregiver’s own life becomes centered around the patient’s needs, which can lead to caregiver burnout, stress, and health problems.

Practical coping strategies can help patients and families manage these challenges. Accepting help from others is crucial—friends and community members often genuinely want to contribute, whether by bringing meals, providing transportation to appointments, or simply spending time with the patient. Joining support groups, either in person or online, connects patients and families with others who truly understand what they are experiencing. Professional counseling or speaking with a chaplain can provide emotional and spiritual support during this difficult time.

Open, honest communication within the family helps everyone process their feelings and make important decisions together. Setting small, achievable daily goals gives patients a sense of purpose and accomplishment. Finding adapted ways to enjoy favorite activities, even in modified form, maintains quality of life. For example, someone who loved cooking might enjoy looking through recipe books or suggesting meal ideas even if they can no longer prepare food themselves.

⚠️ Important
Early involvement of palliative care specialists is strongly recommended for all anaplastic thyroid cancer patients, regardless of their treatment plan. Palliative care focuses on relieving symptoms, managing pain, and improving quality of life. This type of care can be provided alongside cancer treatments and is not the same as hospice care or giving up on treatment. Palliative care teams can make a tremendous difference in helping patients and families cope with this disease.

Support for Family: Understanding Clinical Trials

For families facing an anaplastic thyroid cancer diagnosis, understanding the role of clinical trials is important. Clinical trials are research studies that test new treatments or new combinations of existing treatments. Because anaplastic thyroid cancer is so rare and difficult to treat with standard approaches, clinical trials may offer access to promising new therapies that are not yet widely available.

Clinical trials for anaplastic thyroid cancer might test new chemotherapy drugs, targeted therapies that attack specific genetic mutations in the tumor, immunotherapy drugs that help the immune system fight the cancer, or new combinations of surgery, radiation, and medication. Some trials focus on improving quality of life and symptom management rather than directly fighting the tumor.[7][15]

Families should understand that participating in a clinical trial is completely voluntary. There is never any obligation to join a trial, and patients can withdraw at any time if they choose. However, for patients with anaplastic thyroid cancer, where standard treatments often have limited effectiveness, clinical trials may represent the best opportunity to access cutting-edge treatments that could potentially extend life or improve its quality.

Not all patients are eligible for every clinical trial. Trials have specific requirements regarding the stage of cancer, previous treatments received, the patient’s overall health status, and sometimes the specific genetic characteristics of the tumor. The medical team can help determine which trials, if any, might be appropriate for a particular patient.

How can family members support their loved one in finding and preparing for clinical trial participation? First, they can help research what trials are currently available. Major cancer centers often have clinical trial coordinators who can provide information about studies being conducted at their institution. Online databases allow searching for trials by cancer type and location. The patient’s oncologist may also know about relevant trials and can provide referrals.

Family members can help by attending appointments where clinical trials are discussed, taking notes, and asking questions. Understanding the details of a trial—including what treatments are involved, what side effects are possible, how often appointments will be required, and whether travel to a different medical center will be needed—helps the patient make an informed decision.

If the patient decides to participate in a trial, family support remains crucial. Keeping track of appointments and medication schedules becomes more complex in a research setting. Transportation to and from the medical center, especially if it is far from home, may require significant planning and assistance. Monitoring for side effects and promptly reporting any problems to the research team is essential.

Families should also help ensure that the patient’s questions and concerns are heard by the research team. Clinical trials involve a significant amount of paperwork, consent forms, and information. Making sure the patient truly understands what they are agreeing to and feels comfortable with the plan is an important advocacy role for family members.

It is equally important for families to understand that even in a clinical trial, there are no guarantees. The new treatment being studied may not work for their loved one, or it may cause difficult side effects. Clinical trials also involve more monitoring, testing, and data collection than standard treatment, which can add to the patient’s burden. Balancing hope for benefit with realistic expectations is challenging but necessary.

Throughout the journey, families should encourage the patient to openly discuss their goals and preferences. Some patients want to pursue every possible treatment option, including experimental ones, to try to extend their life as long as possible. Others may prioritize quality of life and comfort over aggressive treatment. There is no single “right” choice, and the patient’s wishes should guide decision-making.

Finally, families should also care for themselves during this time. The stress of supporting a loved one with anaplastic thyroid cancer can be overwhelming. Seeking support from friends, joining caregiver support groups, and taking breaks when possible are not selfish acts—they are necessary for maintaining the strength to continue providing care and support.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Dabrafenib (Tafinlar) – A targeted therapy drug approved by the FDA for treating locally advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation, typically used in combination with trametinib.
  • Trametinib (Mekinist) – A targeted therapy drug used in combination with dabrafenib for anaplastic thyroid cancer with BRAF V600E mutation when satisfactory locoregional treatment options are not available.
  • Lenvatinib (Lenvima) – A multitarget tyrosine kinase inhibitor approved in Japan for treating unresectable anaplastic thyroid cancer, and also used in other countries as a targeted therapy option.
  • Sorafenib (Nexavar) – A multitarget tyrosine kinase inhibitor used as targeted therapy for anaplastic thyroid cancer.
  • Selpercatinib (Retevmo) – A targeted therapy drug used for anaplastic thyroid cancer with RET gene changes.
  • Larotrectinib (Vitrakvi) – A targeted therapy drug used for anaplastic thyroid cancer with NTRK gene changes.
  • Entrectinib (Rozlytrek) – A targeted therapy drug used for anaplastic thyroid cancer with NTRK gene changes.
  • Doxorubicin (Adriamycin) – A chemotherapy drug commonly used for anaplastic thyroid cancer, often in combination with cisplatin or as a single agent.
  • Cisplatin – A chemotherapy drug used in combination with doxorubicin for anaplastic thyroid cancer treatment.
  • Paclitaxel – A chemotherapy drug (taxane) that may be used for some cases of anaplastic thyroid cancer.
  • Docetaxel – A chemotherapy drug (taxane) that may be used for some cases of anaplastic thyroid cancer.
  • Pembrolizumab – An immunotherapy drug (anti PD-1/PD-L1 molecule) being evaluated for anaplastic thyroid cancer treatment.
  • Spartalizumab – An immunotherapy drug (anti PD-1/PD-L1 molecule) used for PD-L1 positive anaplastic thyroid cancer tumors.

Ongoing Clinical Trials on Anaplastic thyroid cancer

  • Study on Sacituzumab Govitecan for Patients with Advanced Differentiated and Anaplastic Thyroid Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    France
  • Study of dabrafenib and trametinib combination therapy before and after surgery in patients with BRAF-mutated anaplastic thyroid cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://my.clevelandclinic.org/health/diseases/23539-anaplastic-thyroid-cancer-atc

https://www.thyroid.org/anaplastic-thyroid-cancer/

https://www.ncbi.nlm.nih.gov/books/NBK538179/

https://columbiasurgery.org/conditions-and-treatments/anaplastic-thyroid-cancer

https://thyca.org/atc/about-atc/

https://en.wikipedia.org/wiki/Anaplastic_thyroid_cancer

https://www.mdanderson.org/patients-family/diagnosis-treatment/care-centers-clinics/endocrine-center/fast-clinic.html

https://emedicine.medscape.com/article/283165-overview

https://www.macmillan.org.uk/cancer-information-and-support/thyroid-cancer/anaplastic

https://www.ncbi.nlm.nih.gov/books/NBK538179/

https://my.clevelandclinic.org/health/diseases/23539-anaplastic-thyroid-cancer-atc

https://emedicine.medscape.com/article/283165-treatment

https://www.thyroid.org/anaplastic-thyroid-cancer/

https://cancer.ca/en/cancer-information/cancer-types/thyroid/treatment/anaplastic-thyroid-cancer

https://thyroidresearchjournal.biomedcentral.com/articles/10.1186/s13044-020-00091-w

https://columbiasurgery.org/conditions-and-treatments/anaplastic-thyroid-cancer

https://www.cancer.org/cancer/types/thyroid-cancer/treating/by-stage.html

https://www.mdanderson.org/newsroom/combining-targeted-therapy-and-immunotherapy-improves-overall-survival-in-patients-with-anaplastic-thyroid-cancer.h00-159701490.html

https://www.macmillan.org.uk/cancer-information-and-support/thyroid-cancer/treatment-anaplastic

https://www.mdanderson.org/cancerwise/q-a–anaplastic-thyroid-cancer.h00-159144456.html

https://thyca.org/atc/support/

https://my.clevelandclinic.org/health/diseases/23539-anaplastic-thyroid-cancer-atc

https://www.thyroid.org/anaplastic-thyroid-cancer/

https://www.thyroidcancer.com/thyroid-cancer/anaplastic/follow-up

https://tiro.expert/recommendations/atc/end-of-life-care/

https://columbiasurgery.org/conditions-and-treatments/anaplastic-thyroid-cancer

https://www.youtube.com/watch?v=F-DKZ9w0l9o

https://pmc.ncbi.nlm.nih.gov/articles/PMC3282954/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can anaplastic thyroid cancer be cured?

Complete cure is rare but possible in a very small percentage of patients whose cancer is detected very early (confined only to the thyroid), can be completely removed surgically, and who receive aggressive follow-up treatment. However, most patients are diagnosed when the cancer has already spread or cannot be completely removed, making cure unlikely. Treatment focuses on extending life and maintaining quality of life.

How quickly does anaplastic thyroid cancer grow?

Anaplastic thyroid cancer is one of the fastest-growing tumors in humans. Patients typically notice a neck mass that grows visibly larger over a period of days to weeks, which is dramatically faster than other types of thyroid cancer that may grow slowly over months or years. This rapid growth is why speed in diagnosis and treatment is so critical.

What causes anaplastic thyroid cancer?

The exact cause is unknown. However, risk factors include being over age 60, being female, having a history of other thyroid cancers (papillary or follicular), having a long-standing goiter (enlarged thyroid), and in some cases, previous radiation exposure to the neck or chest. Many cases appear to develop when pre-existing thyroid cancers transform into this more aggressive form.

Why can’t most anaplastic thyroid cancers be removed with surgery?

By the time anaplastic thyroid cancer is diagnosed, it has often grown into surrounding structures like the windpipe (trachea), food pipe (esophagus), major blood vessels, or muscles in the neck. In about half of cases, it has already spread to distant organs like lungs or bones. Complete surgical removal requires being able to take out all cancer tissue with clear margins, which is rarely possible with such extensive local invasion and spread.

Should patients with anaplastic thyroid cancer have genetic testing of their tumor?

Yes, genetic testing of the tumor is strongly recommended and considered mandatory by many experts. Identifying specific mutations (especially BRAF V600E mutation, but also RET, NTRK, and others) can guide treatment decisions and may open the door to targeted therapies that work specifically against those genetic changes. These targeted treatments may be more effective than standard chemotherapy for patients whose tumors have the matching mutations.

🎯 Key takeaways

  • Anaplastic thyroid cancer is extremely rare (less than 2% of thyroid cancers) but extraordinarily aggressive, with median survival of 3-6 months after diagnosis.
  • The cancer typically presents as a rapidly growing, rock-hard neck mass that appears over days to weeks and can quickly cause breathing and swallowing difficulties.
  • All anaplastic thyroid cancers are classified as Stage IV at diagnosis due to their aggressive nature, with 50% already having spread to distant organs at detection.
  • Complete surgical removal is rarely possible because the tumor usually invades surrounding structures or has spread beyond the neck by the time it is discovered.
  • Genetic testing of the tumor is essential because targeted therapies like dabrafenib plus trametinib can be effective for tumors with specific mutations like BRAF V600E.
  • Despite grim statistics, there are documented long-term survivors who have lived for years after treatment, particularly those diagnosed at earlier stages.
  • Palliative care should be involved early in all cases to help manage symptoms, pain, and quality of life throughout the disease course.
  • Clinical trials may offer access to promising new treatments not yet widely available and should be considered for eligible patients.